Vibrio cholerae: Cholera and Its Effects

Cholera remains one of the most feared infectious diseases worldwide, capable of killing within hours if left untreated. At the heart of this deadly illness lies a tiny bacterium with a distinctive shape – Vibrio cholerae. Understanding this microorganism is essential for healthcare professionals, especially nurses who play a critical role in patient care during outbreaks.

What is Vibrio cholerae?
Classification and serogroups
How cholera toxin causes disease
The mechanism of action
Clinical presentation and effects
Symptoms of cholera
Transmission and risk factors
Laboratory diagnosis
Diagnostic approaches
Treatment principles
Rehydration therapy
Antibiotic therapy
Zinc supplementation
Prevention strategies
The nursing role in cholera management

What is Vibrio cholerae?

Vibrio cholerae is a highly motile, Gram-negative, curved or comma-shaped bacterium with a single polar flagellum that enables rapid movement. The bacterium typically measures 1-3 µm in length and 0.5-0.8 µm in diameter. It is a facultative anaerobe, meaning it can survive with or without oxygen, and naturally inhabits brackish or saltwater environments where it attaches to the shells of crabs, shrimp, and other shellfish.

The organism was first correctly identified as a bacterium by Italian physician Filippo Pacini during a cholera outbreak in Florence in 1854. However, its medical significance wasn’t fully established until German physician Robert Koch isolated it in pure culture in 1883. The bacterium-cholera relationship was definitively proven in 1959 when Indian physician Sambhu Nath De isolated the cholera toxin and demonstrated it as the disease-causing agent.

Classification and serogroups

V. cholerae is classified into more than 200 serogroups based on the structure of the O-antigen of lipopolysaccharide (LPS). However, only serogroups O1 and O139 can cause cholera outbreaks because of their ability to produce cholera toxin. Other serogroups, referred to as non-O1/non-O139, typically cause minor gastroenteritis but do not trigger epidemic cholera.

The O1 serogroup has two biotypes: Classical and El Tor. The El Tor biotype, which predominates in modern outbreaks, tends to produce milder illness but survives better in the environment and has a higher tendency to become endemic. According to the World Health Organization, V. cholerae O1 has caused all recent outbreaks, while O139 has only been identified in sporadic cases recently.

How cholera toxin causes disease

The hallmark of cholera pathogenesis is the cholera toxin (CT), which is responsible for the severe watery diarrhoea characteristic of the disease. This toxin has a unique AB5 structure – one enzymatically active A subunit and five identical B subunits that bind to receptors on intestinal cells.

The mechanism of action

When V. cholerae enters the body through contaminated food or water, it passes through the stomach and colonizes the small intestine using toxin-coregulated pili (TCP). Once attached to intestinal epithelial cells, the bacteria release cholera toxin. The B subunits bind to GM1 ganglioside receptors on the cell surface, allowing the toxin to enter the cell through endocytosis.

Inside the cell, the A1 subunit activates adenylate cyclase through ADP-ribosylation of the Gsα protein. This locks the enzyme in an active state, causing a dramatic increase in cyclic AMP (cAMP) levels. The elevated cAMP activates protein kinase A, which phosphorylates chloride channels (CFTR), resulting in massive secretion of chloride, bicarbonate, sodium, and water into the intestinal lumen. Simultaneously, sodium and water absorption is inhibited. The result? Profuse watery diarrhoea that can reach 1-2 litres per hour in severe cases.

Clinical presentation and effects

Cholera is an acute secretory diarrheal disease with an incubation period ranging from a few hours to 5 days. The clinical spectrum varies widely – in endemic areas, 75% of cases are asymptomatic, 20% have mild to moderate symptoms, and only 2-5% develop severe disease.

Symptoms of cholera

The disease typically presents with abrupt onset of profuse, painless, watery diarrhoea often described as having a “rice-water” appearance due to its grey, cloudy nature. This is frequently accompanied by vomiting and abdominal cramps. Severe cholera results in rapid dehydration and is associated with high mortality if not treated promptly.

Signs of dehydration include intense thirst, dry mucous membranes, decreased skin turgor, sunken eyes, hypotension, weak or absent radial pulse, tachycardia, and reduced urine output. In untreated severe cases, dehydration can lead to hypovolemic shock, metabolic acidosis, acute renal failure, seizures, coma, and death – sometimes within hours of symptom onset.

Transmission and risk factors

Cholera is transmitted through the fecal-oral route, primarily by consuming water or food contaminated with infectious faeces. The disease indicates inequity and lack of social and economic development, thriving in areas with poor sanitation and limited access to safe drinking water.

Specific risk factors for infection include consuming untreated water, eating raw or undercooked seafood (especially shellfish), poor hand hygiene, and living in crowded conditions. People with low gastric acidity or blood type O are at higher risk for severe infection. The infectious dose is quite high – between 10⁶ and 10¹¹ organisms – though this decreases significantly in individuals with reduced stomach acid.

Laboratory diagnosis

Confirming cholera requires laboratory testing, though treatment should never be delayed while awaiting results. The most common method is isolating V. cholerae from stool specimens followed by O1 and O139 serotyping.

Diagnostic approaches

Stool examination: Direct microscopy of fresh stool using dark-field illumination can detect the characteristic darting motility of vibrios. The organisms appear as comma-shaped bacteria with rapid movement that is immobilized by specific antisera.

Culture methods: Selective media containing bile salts, such as thiosulfate-citrate-bile-sucrose (TCBS) agar, are recommended because V. cholerae can grow at high pH and in bile salts that inhibit other bacteria. On TCBS agar, the bacteria form large, smooth, yellow colonies that stand out against the blue-green medium.

Rapid diagnostic tests: Dipstick tests allow quick confirmation in remote areas, helping reduce mortality at the start of outbreaks. However, positive RDT results should be confirmed by culture or PCR.

Molecular methods: PCR testing offers high sensitivity and can detect molecular markers such as ctxA, tcpA, and ompW genes. While PCR delivers faster results than culture, it requires specialized laboratory capacity often lacking in resource-limited settings.

Treatment principles

Cholera is remarkably treatable when addressed promptly. Without treatment, approximately half of patients with severe cholera may die, but with appropriate rehydration, fatality rates drop below 1%.

Rehydration therapy

The cornerstone of treatment is aggressive fluid and electrolyte replacement. Most patients with mild to moderate dehydration can be managed with oral rehydration solution (ORS). The WHO-recommended low-osmolarity ORS contains sodium, chloride, potassium, citrate, and glucose dissolved in sterile water. Patients with severe dehydration require intravenous fluids, typically lactated Ringer’s solution, followed by ORS once they can tolerate oral intake.

Antibiotic therapy

While not essential for all cases, antibiotics shorten the duration of diarrhoea and reduce stool volume by up to 50% in severely ill patients. Commonly used antimicrobials include doxycycline, azithromycin, and ciprofloxacin, with the choice depending on local resistance patterns. The WHO recommends antibiotics for severe cases regardless of age and for hospitalized patients.

Zinc supplementation

Research has demonstrated that zinc supplementation can decrease the duration and severity of diarrhoea in children with cholera.

Prevention strategies

Preventing cholera requires a multi-pronged approach. The long-term solution lies in economic development and ensuring universal access to safe drinking water, sanitation, and hygiene (WASH). During outbreaks, targeted WASH interventions can significantly reduce transmission.

Oral cholera vaccines (OCV) provide additional protection. Three WHO-prequalified vaccines are currently available: Dukoral®, Euvichol-Plus®, and Euvichol-S®. Due to global vaccine shortages, single-dose regimens are being used to extend coverage during outbreaks.

The nursing role in cholera management

Nurses are essential in cholera response, from early case identification to rehydration management and infection control. Key responsibilities include rapid assessment of dehydration status, accurate calculation and administration of fluid replacement, continuous monitoring of vital signs and urine output, maintaining strict infection control practices, and educating patients and communities about prevention.

What do you think? Considering the rapid progression of severe cholera, how might early warning systems and community-based oral rehydration points change outcomes in endemic regions? What role can nurses play in strengthening cholera surveillance in healthcare settings?

References

PDF 📄

Table of Contents

What is Vibrio cholerae? 🔗

Classification and serogroups 🔗

How cholera toxin causes disease 🔗

The mechanism of action 🔗

Clinical presentation and effects 🔗

Symptoms of cholera 🔗

Transmission and risk factors 🔗

Laboratory diagnosis 🔗

Diagnostic approaches 🔗

Treatment principles 🔗

Rehydration therapy 🔗

Antibiotic therapy 🔗

Zinc supplementation 🔗

Prevention strategies 🔗

The nursing role in cholera management 🔗